Romatoid artritli hastalarda sensörinöral işitme kaybı
Yükleniyor...
Tarih
2011
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Dicle Üniversitesi Tıp Fakültesi
Erişim Hakkı
Attribution-NonCommercial 3.0 United States
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Amaç: Romatoid artrit (RA)’li hastalarda işitme kaybı oranını, tipini ve mevcut kaybın kontrol grubuna göre farklı olup olmadığını araştırmak. Gereç ve yöntem: Çalışmaya 50 RA hastası ve 34 sağlıklı kontrol grubu alındı. Her iki gruptakilere; 250-8.000 Hz frekanslar arasında pür tone odyometri, stapes refleksi ve Oto Akustik Emisyon testi yapıldı. Bulgular: Olguların yaş ortalaması RA’lı hastalarda 36,88 ± 8,81 yıl ve kontrol grubunda 35,58 ± 8,19 yıl olarak bulundu. Ortalama hastalık süresi RA’da 4,72 (0-21) yıl
bulundu. RA’lı hastaların 10’ unda (%20) ve kontrol grubunun 3’ ünde (%8,8) işitme kaybı saptandı. İşitme kaybı açısından gruplar arasında istatistiksel olarak anlamlı bir fark bulunmadı (p=0,139). Romatoid artritli hastalarda %14 ve kontrol grubundakilerde %8,8 olmak üzere her iki grupta da en sık sensörinöral tip işitme kaybı (SNİK) bulundu. Hastalık süresi 10 yıldan fazla olan yedi RA’lı hastanın 6’sında (%85.7) işitme kaybı mevcuttu. Sonuç: Romatoid artrit ve kontrol grubu arasında işitme kaybı açısından anlamlı fark bulunmadı. RA’lı hastalarda hastalık süresi uzadıkça işitme kaybı görülme oranı artmaktadır.
Objectives: The aim of this study was to evaluate the rate and type of the hearing loss in patients with rheumatoid arthritis (RA); and to analyze whether these hearing loss rates were different from control group or not. Materials and methods: The study included 50 RA patients and 34 healthy control subjects. All two groups underwent, pure tone audiometric test between 250-8.000 Hz frequencies; stapes reflex test and otoacoustic emissions. Results: The mean ages were 36, 88 ± 8, 81 years in RA cases and 35, 58 ± 8, 19 years in control group. The mean disease duration was 4.72 (range 2-21) years in patients with RA. Hearing loss was detected in 10 (20%) of the RA patients and 3 (8.8%) of the control group. The difference between the groups was not statistically significant in terms of hearing loss (p=0,139). The sensorineural hearing loss was the most commonly detected hearing loss type. The distribution of this type of hearing loss was 14% in RA and 8.8% in control group. Hearing loss was present in 6 (85.7%) of the seven RA patients whose duration of the disease was more than 10 years. Conclusion: There was not found significant difference between RA and control group with respect to hearing loss. In RA cases, the degree of hearing loss was increasing with the duration of the diseases.
Objectives: The aim of this study was to evaluate the rate and type of the hearing loss in patients with rheumatoid arthritis (RA); and to analyze whether these hearing loss rates were different from control group or not. Materials and methods: The study included 50 RA patients and 34 healthy control subjects. All two groups underwent, pure tone audiometric test between 250-8.000 Hz frequencies; stapes reflex test and otoacoustic emissions. Results: The mean ages were 36, 88 ± 8, 81 years in RA cases and 35, 58 ± 8, 19 years in control group. The mean disease duration was 4.72 (range 2-21) years in patients with RA. Hearing loss was detected in 10 (20%) of the RA patients and 3 (8.8%) of the control group. The difference between the groups was not statistically significant in terms of hearing loss (p=0,139). The sensorineural hearing loss was the most commonly detected hearing loss type. The distribution of this type of hearing loss was 14% in RA and 8.8% in control group. Hearing loss was present in 6 (85.7%) of the seven RA patients whose duration of the disease was more than 10 years. Conclusion: There was not found significant difference between RA and control group with respect to hearing loss. In RA cases, the degree of hearing loss was increasing with the duration of the diseases.
Açıklama
Anahtar Kelimeler
Romatoid artrit, Hastalık süresi, İşitme kaybı, Rheumatoid arthritis, Disease duration, Hearing loss
Kaynak
Dicle Tıp Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
38
Sayı
2
Künye
Bozkurt, M., Gün, R., Gür, A., Uçar, D. ve Nas, K. (2011). Correlation of high sensitive C-reactive protein and Hepatitis C Virus RNA in anti-HCV-positive sera. Dicle Tıp Dergisi, 38(2), 184-188.
